2013 - Fellow of the American Association for the Advancement of Science (AAAS)
Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA
Matthew R. Redinbo;Lance Stewart;Peter Kuhn;James J. Champoux.
The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity
R. E. Watkins;G. B. Wisely;L. B. Moore;J. L. Collins.
A model for the mechanism of human topoisomerase I.
Lance Stewart;Matthew R. Redinbo;Xiayang Qiu;Wim G. J. Hol.
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme
Bret D. Wallace;Hongwei Wang;Kimberly T. Lane;John E. Scott.
Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4.
Madhukumar Venkatesh;Subhajit Mukherjee;Hongwei Wang;Hao Li.
Crystal structure of an ancient protein: evolution by conformational epistasis.
Eric A. Ortlund;Jamie T. Bridgham;Matthew R. Redinbo;Joseph W. Thornton.
Regulation of CYP3A gene transcription by the pregnane X receptor
Bryan Goodwin;Matthew R. Redinbo;Steven A. Kliewer.
Annual Review of Pharmacology and Toxicology (2002)
2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin.
Ryan E. Watkins;Jodi M. Maglich;Linda B. Moore;G. Bruce Wisely.
The role of the microbiome in cancer development and therapy
Aadra P. Bhatt;Matthew R. Redinbo;Scott J. Bultman.
CA: A Cancer Journal for Clinicians (2017)
Mammalian carboxylesterases: from drug targets to protein therapeutics.
Matthew R. Redinbo;Philip M. Potter.
Drug Discovery Today (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: